Diagnosis and classification of systemic sclerosis

Clinical Reviews in Allergy and Immunology

Volumn 40, Issue 2, 2011, Pages 78-83

  Hachulla, Eric ^a   Launay, David ^a  

^a UNIV LILLE   (France)

Author keywords

Classification; Diagnosis; Scleroderma; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ARTICLE; CAPILLAROSCOPY; DISEASE CLASSIFICATION; HUMAN; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SCLERODERMA; SKIN FIBROSIS; SKINFOLD; SYNDROME CREST; SYSTEMIC SCLEROSIS;

HUMANS; SCLERODERMA, SYSTEMIC;

EID: 79951682352     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-010-8198-y     Document Type: Article

References (19)

1. MD Mayes JV Lacey Jr J Beebe-Dimmer, et al. 2003 Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population Arthritis Rheum 48 2246 2255 10.1002/art.11073 12905479 (Pubitemid 36959206)
2. V Le Guern A Mahr L Mouthon D Jeanneret M Carzon L Guillevin 2004 Prevalence of systemic sclerosis in a French multi-ethnic county Rheumatology (Oxford) 43 1129 1137 10.1093/rheumatology/keh253 (Pubitemid 39232818)
3. L Scussel-Lonzetti F Joyal JP Raynauld, et al. 2002 Predicting mortality in systemic sclerosis: analysis of a cohort of 309 off French Canadian patients with emphasis on features at diagnosis as predictive factors for survival Medicine (Baltimore). 81 154 167 10.1097/00005792-200203000-00005 (Pubitemid 34218570)
4. VD Steen TA Medsger 2007 Changes in causes of death in systemic sclerosis, 1972-2002 Ann Rheum Dis 66 940 944 10.1136/ard.2006.066068 17329309 (Pubitemid 46999798)
5. MC Vonk B Broers YF Heijdra, et al. 2008 Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study Ann Rheum Dis 68 961 965 10.1136/ard.2008.091710 18511546
6. JD Reveille DH Solomon American College of Rheumatology Ad Hoc Committee of Immunologic Testing Guidelines 2003 Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies Arthritis Rheum 49 399 412 10.1002/art.11113 12794797 (Pubitemid 36682409)
7. N Hunzelmann E Genth T Krieg, et al. 2008 The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement Rheumatology 47 1185 1192 1:STN:280:DC%2BD1cvlsVOmsA%3D%3D 10.1093/rheumatology/ken179 18515867 (Pubitemid 352038224)
8. SR Johnson BM Feldman GA Hawker 2007 Classification criteria for systemic sclerosis subsets J Rheumatol 34 1855 1863 17696271 (Pubitemid 350067646)
9. AT Masy GP Rodnan TA Medsger Jr RD Altman WA D'angelo JF Fries the Subcommittee for Scleroderma Criteria of American Rheumatism Association Diagnostic and Therapeutic Criteria Committee 1980 Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 581 590 10.1002/art.1780230510 (Pubitemid 10101764)
10. Medsger TA Jr (1985) Comment on Scleroderma Criteria Cooperative Study. In: Black CM, Myers AR (eds) Current topics in rheumatology: systemic sclerosis (scleroderma). Gower Medical Publishing, New York, pp 16-17
11. LS Lonzetti F Joyal JP Raynauld, et al. 2001 Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma Arthritis Rheum 44 735 736 1:STN:280:DC%2BD3M7mtlymtg%3D%3D 10.1002/1529-0131(200103)44:3<735::AID- ANR125>3.0.CO;2-F 11263791 (Pubitemid 32234635)
12. OC Meyer N Fertig M Lucas N Somogyi TA Medsger Jr 2007 Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis J Rheumatol. 34 104 109 17117486 (Pubitemid 46106569)
13. EC LeRoy C Black R Fleischmajer, et al. 1988 Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 202 205 1:STN:280:DyaL1c3gtVWnsg%3D%3D 3361530 (Pubitemid 18073738)
14. TA Medsger Jr 2003 Natural history of systemic sclerosis and assessment of disease activity, severity, functional status, and psychologic well-being Rhum dis Clin N Am 29 255 273 10.1016/S0889-857X(03)00023-1 (Pubitemid 36765120)
15. H Penn AJ Howie EJ Kingdon CCRJ Bunn, et al. 2007 Scleroderma renal crisis: patient characteristics and long-term outcomes Q J Med 100 485 494 1:STN:280:DC%2BD2svjtVWgtQ%3D%3D (Pubitemid 47241915)
16. RH Winterbauer 1964 Multiple telangiectasia, Raynaud's phenomenon, sclerodactyly, and subcutaneous calcinosis: a syndrome mimicking hereditary hemorrhagic telangiectasia Bull Johns Hopkins Hosp 114 361 383 1:STN:280:DyaF2c7ivFKitA%3D%3D 14171636
17. AJ Barnett M Miller GO Littlejohn 1988 The diagnosis and classification of scleroderma (systemic sclerosis) Postgrad Med J 64 121 125 1:STN:280:DyaL1M%2Fhs12jsQ%3D%3D 10.1136/pgmj.64.748.121 3050937 (Pubitemid 18068758)
18. EC LeRoy TA Medsger Jr 2001 Criteria for the classification of early systemic sclerosis J Rheumatol 28 1573 1576 1:STN:280:DC%2BD38%2Fit1Oqsw%3D%3D 11469464
19. H Poormoghim M Lucas N Fertig TA Medsger Jr 2000 Systemic sclerosis sine scleroderma. Demographic, clinical, and serological features and survival in forty-eight patients Arthritis Rheum 43 444 451 1:STN:280:DC%2BD3c7lsFGmtg%3D%3D 10.1002/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G 10693887 (Pubitemid 30395756)